市場調查報告書
商品編碼
1547880
全球左心耳封堵器市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Left Atrial Appendage Closure Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球左心耳封堵器市場需求預計將從 2023 年的 22.4 億美元達到 2032 年近 67.3 億美元的市場規模,2024-2032 年研究期間複合年成長率為 13.01%。
左心耳封堵裝置透過封閉心臟中一個小的、不必要的部分(稱為左心耳)來幫助預防中風。此裝置可有效消除左心耳血液聚集的可能性。該裝置透過手術植入。在全身麻醉下透過各種方法植入不同的左心耳封堵器,這意味著患者在整個手術過程中處於睡眠狀態。設備幫助可以從外部角度或內部血液暴露設備來實現。
中風對於心房顫動患者來說是一個嚴重的風險。如果治療不當,心房顫動患者發生中風的風險更高。心房顫動 (AFib) 是最廣泛認知的心律異常,影響全球超過 3,300 萬人。心房顫動的日益普及將推動市場的成長。此外,政府為提高公眾對心血管疾病的認知而採取的舉措激增以及有吸引力的健康保險政策可能會影響左心耳封堵器市場的成長。然而,植入左心耳封堵器也存在短期和長期風險。此外,設備植入程序並不能完全消除血栓的可能性,這阻礙了市場的成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球左心耳封堵器市場的各個細分市場進行了包容性評估。左心耳封堵器產業的成長和趨勢為本研究提供了整體方法。
左心耳封堵器市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲左心耳封堵器市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。左心耳封堵器市場的主要參與者包括波士頓科學公司、LifeTech Scientific、Occlutech、強生公司、AtriCure Inc.、雅培實驗室公司。的併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Left Atrial Appendage Closure Device Market is presumed to reach the market size of nearly USD 6.73 Billion by 2032 from USD 2.24 Billion in 2023 with a CAGR of 13.01% under the study period 2024-2032.
Left atrial appendage closure device helps prevent stroke by sealing off a small, unnecessary section of the heart called the left atrial appendage. The device is effective at eliminating the possibility of blood collecting in the left atrial appendage. The device is implanted by surgery. There are different LAA closure devices implanted by various methods performed under general anaesthesia, meaning the patient is asleep during the whole procedure. Device help can be achieved from an outside perspective or an inside blood exposed device.
Stroke is a serious risk for patients with atrial fibrillation. Patients with atrial fibrillation are at a higher danger of stroke if not appropriately treated. Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world. The growing prevalence of atrial fibrillation will be driving the growth of the market. Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market. However, implantation of an LAA occluder device also entails short-term and long-term risks. Also, device implantation procedures do not totally eliminate the possibility of blood clots which is hampering the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Left Atrial Appendage Closure Device. The growth and trends of Left Atrial Appendage Closure Device industry provide a holistic approach to this study.
This section of the Left Atrial Appendage Closure Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Left Atrial Appendage Closure Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Left Atrial Appendage Closure Device market include Boston Scientific Corporation, LifeTech Scientific, Occlutech, Johnson & Johnson, AtriCure Inc., Abbott Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.